Comparison between Mono Pharmacare IPO and Sungarner Energies IPO.
IPO Details
Mono Pharmacare IPO is a SME Fixed Price IPO proposed to list at NSE SME while Sungarner Energies IPO is a SME Fixed Price proposed to list at NSE SME.
Issue Size and Price
The total issue size of Mono Pharmacare IPO is up to ₹14.07 Cr whereas the issue size of the Sungarner Energies IPO is up to ₹4.83 Cr. The final issue price of Mono Pharmacare IPO is ₹28.00 per share and of Sungarner Energies IPO is ₹83.00 per share.
IPO Timetable
Mono Pharmacare IPO opens on Aug 28, 2023, while Sungarner Energies IPO opens on Aug 21, 2023. The closing date of Mono Pharmacare IPO and Sungarner Energies IPO is Aug 30, 2023, and Aug 23, 2023, respectively.
| | Mono Pharmacare IPO | Sungarner Energies IPO |
|---|
| Issue Open | Aug 28, 2023 | Aug 21, 2023 |
| Issue Close | Aug 30, 2023 | Aug 23, 2023 |
| Basis Of Allotment (Tentative) | Sep 04, 2023 | Aug 28, 2023 |
| Initiation of Refunds (Tentative) | Sep 05, 2023 | Aug 29, 2023 |
| Credit of Share (Tentative) | Sep 06, 2023 | Aug 30, 2023 |
| Listing date (Tentative) | Sep 07, 2023 | Aug 31, 2023 |
Financials & KPIs
Mono Pharmacare IPO P/E ratio is , as compared to Sungarner Energies IPO P/E ratio of 13.07.
Shares Offered
In the Mono Pharmacare IPO Retail Individual Investors (RII) are offered 22,64,000 shares while in Sungarner Energies IPO retail investors are offered 22,64,000 shares. Qualified Institutional Buyers (QIB) are offered 5,00,000 shares in Mono Pharmacare IPO and in Sungarner Energies IPO.
| | Mono Pharmacare IPO | Sungarner Energies IPO |
|---|
| Market Maker Reservation | 2,76,000 shares | 57,600 shares |
| QIB | 5,00,000 shares | |
| NII | 22,60,000 shares | 2,91,200 shares |
| RII | 22,64,000 shares | 2,91,200 shares |
| Total | 50,24,000 shares | 5,82,400 shares |
Bids Received (Subscription)
Mono Pharmacare IPO subscribed 13.42x in total, whereas Sungarner Energies IPO subscribed 151.76x.
